Article

From feasibility to clinical pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015–2025)

2025-12-16

Abstract excerpt

<title>Abstract</title> <p>Background Urologic cancers, including prostate cancer, bladder cancer, upper tract urothelial carcinoma and renal cell carcinoma, are well suited to urine-based liquid biopsy because tumors lie close to the urinary tract and often require repeated, minimally invasive monitoring. Over the past decade, multiple urinary analytes and platforms have been explored, but an integrated view of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 161d36f3-def9-56f2-99f2-63bc16cbe65c
DOI: 10.21203/rs.3.rs-8287024/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

From feasibility to clinical pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015–2025)DOI 10.21203/rs.3.rs-8287024/v1Read

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysSemantic proximity Read

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read

Landscaping of Urine Proteome: Unlocking Diagnostic Potential and Overcoming Unique ChallengesSemantic proximity Read

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder CancerSemantic proximity Read

Integrated multi-omics analyses reveal causal insights into the molecular landscape of urologic cancersSemantic proximity Read

GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity Read

Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer PatientsSemantic proximity Read

Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations.Semantic proximity Read

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerSemantic proximity Read

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read